Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most adults who qualify, taking weight loss injections such as tirzepatide (Mounjaro) or semaglutide (Wegovy) is considered safe when prescribed and monitored by a qualified clinician. Both medicines have passed rigorous regulatory review by the MHRA and are licensed for use in the UK. That said, "safe" does not mean without any risk: side effects are common, a small number are serious, and the medicines are prescription-only for good reason. Every person's suitability is assessed individually before a prescription is issued, because a prescriber needs to weigh your full medical history against what the evidence shows. If you are considering this route, understanding what these injections involve before you start is the most useful thing you can do.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The overwhelming majority of people who take GLP-1 or dual GIP/GLP-1 injections experience some digestive disruption, especially in the early weeks. Nausea is the one patients mention most; vomiting, loose stools, constipation, reflux and burping all appear regularly in trial data. Fatigue, mild headache and dizziness are also reported. The NHS medicines page for tirzepatide lists these clearly, as does the equivalent page for semaglutide. What the data also shows is that these effects peak at the beginning of treatment or shortly after a dose increase, then ease for most people within a few days to two weeks.
Injection-site reactions (redness, mild swelling, a brief itch) are worth knowing about too. Rotating the site (abdomen, thigh, upper arm) at each weekly dose reduces that. The practical side of taking the injection is simpler than most people expect once they have held the pen, which arrives pre-filled and ready to use.
Less common but documented effects include gallbladder problems, hair thinning (usually temporary, linked to rapid weight loss rather than the medicine itself), and a raised heart rate in some people. A prescriber reviews these risks against your personal history before any prescription is written.
Most GI side effects are unpleasant but not dangerous. A few signals are different and need prompt attention. Severe, persistent stomach pain that radiates toward the back, with or without vomiting, is the key symptom associated with acute pancreatitis. In January 2026, following a review of post-market data, the MHRA issued a Drug Safety Update specifically highlighting pancreatitis as an infrequent but serious risk with GLP-1 medicines, and advised patients to seek urgent care if they develop this symptom pattern.
Other reasons to seek same-day or emergency medical attention include signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing), symptoms of gallbladder problems (severe pain in the upper right abdomen, yellowing of the skin), or dehydration caused by persistent vomiting or diarrhoea that you cannot manage by sipping fluids. If you notice low mood, unusual thoughts, or any thoughts of self-harm, contact your GP or call 111.
If you experience a side effect you were not expecting, you can report it directly to the MHRA via the Yellow Card scheme. This reporting genuinely contributes to the ongoing safety picture for these medicines.
The licensing criteria are specific, and for good reason. These medicines are not recommended during pregnancy, while breastfeeding, or for anyone actively trying to conceive. They are not licensed for people under 18. A personal or family history of medullary thyroid carcinoma or a condition called multiple endocrine neoplasia type 2 is a contraindication; a history of pancreatitis or certain gastrointestinal conditions requires careful prescriber discussion before any treatment is started.
Oral contraceptives deserve a specific mention. Because tirzepatide slows the passage of food through the gut, it can reduce absorption of a pill taken at the same time. NHS guidance advises using an additional non-oral method of contraception for the first four weeks of tirzepatide and for four weeks after each dose increase. The NHS England guidance on weight management injections covers this in detail, along with advice about HRT and informing surgical teams before any planned procedure.
BMI thresholds also form part of the eligibility picture, though they are the starting point rather than the whole conversation. A consultation with a prescriber is where individual factors are properly considered, not a checklist you complete alone.
Yes, materially. The MHRA has made a series of seizures of counterfeit weight loss pens, with roughly 20 million doses (approximately £45m street value) of illegally traded medicines removed from circulation in 2025 alone, including a raid on a domestic manufacturing site producing fake tirzepatide pens. Counterfeit products have been found to contain insulin and other incorrect substances.
A GPhC-registered pharmacy, verifiable on the GPhC register, is the only lawful route to these prescription-only medicines in the UK. At nume, every consultation is reviewed by a named GPhC-registered Independent Prescriber, not an automated system. Photo ID and live weight verification happen before any prescription is issued. If approved, treatment is dispatched the same day and arrives via DPD the next working day in plain, unbranded packaging, tracked to your door. That chain of custody matters for a medicine where the counterfeit risk is real.
If you want to understand whether it is safe to take injections for weight loss and what the evidence says, or explore what dietary support looks like alongside treatment, those questions are worth exploring before you start. Our prescribers discuss suitability and side effects as part of every consultation, start yours here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.